Live Breaking News & Updates on Pharma outlook 2024

Stay updated with breaking news from Pharma outlook 2024. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Nifty Pharma hits all-time high; 10 stocks including Lupin, Cipla, Glenmark Pharma, Divi's Labs touch one-year peaks

In today's trade, Lupin's shares soared nearly 7%, hitting a new all-time high of ₹1,404 apiece after Japanese brokerage firm Nomura raised the target price on the stock to ₹1,593 apiece from the previous ₹1,290, maintaining its 'buy' recommendation.

India , United-states , Japan , Japanese , Prathamesh-masdekar , Sun-pharma , Motilal-oswal , Aurobindo-pharma , Zydus-lifesciences , Research-analyst-at-stoxbox , Glenmark-pharmaceuticals , Glaxosmithkline-pharmaceuticals